Guidance

Flublok Quadrivalent vaccine: patient group direction template

Patient group direction (PGD) template for administering Flublok Quadrivalent vaccine in accordance with national seasonal flu vaccination programme.

From:
Public Health England
Published
24 November 2020

This publication was withdrawn on

This PGD has been withdrawn as it was only for use in the 2020 to 2021 flu vaccination programme. PGDs for the current flu programme are available to download.

Documents

[Withdrawn] Flublok Quadrivalent Patient Group Direction (PGD)

Ref: PHE gateway number GW-1750

MS Word Document, 138 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of Flublok Quadrivalent vaccine as part of the national seasonal influenza vaccination programme.

Flublok Quadrivalent PGD V01.00 is valid from 23 November 2020 to 31 March 2021.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012. Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and UK Patient Information Leaflet (PIL) for the vaccine.

Published 24 November 2020

Related content